Please enable JS

DISCOVER

tech ALLIANCE

A technological ecosystem
of technological partners

The TECH Alliance ecosystem consists of a network of technology providers selected for the quality and innovative relevance of their products and services, creating a plug-and-play integrated offer to extend the Telemedicine Technologies business solution, CleanWeb, in full compliance with clinical and regulatory requirements.

Interested to be part of the TECH Alliance or just want to learn more?

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Join Telemedicine Technologies at EUCROF26!

October 30, 2025

February 1–3, 2025 – Amsterdam | Booth 16-17-18 We’re excited to announce our participation to EUCROF26! Visit our booth to explore CleanWeb™, our advanced eClinical suite for managing clinical trials, registries, and early access programs. Together with our CRO Alliance partners (BlueCompanion, Clinica Group, DeltaClinical, NextCRO, Phoenix CR), we offer tailored solutions to support your […]

READ MORE
telemedecine technologies news

Bringing Clinical Trials Into the Digital Era with eConsent

October 30, 2025

Applied Clinical Trials Online Clinical trials have traditionally relied on paper-based consent forms to secure the participant’s approval. While this approach is still common in many studies, it presents practical challenges. Participants may struggle with dense medical jargon, documents can be misplaced, and re-consenting often adds to site workload. As decentralized and hybrid trial models […]

READ MORE
telemedecine technologies news

Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care

October 30, 2025

Biopharm International To improve patient outcomes, experience, and engagement, patient-centric drug development is essential. By focusing on patients’ needs, experiences, and preferences, drug developers can create treatments that are optimally effective and tolerated. This leads to improved adherence to treatment regimens and better overall health outcomes when compared with not taking these factors into consideration […]

READ MORE